| # | Drug | Count |
|---|---|---|
| 0 | ETONOGESTREL | 6622 |
| 1 | COPPER | 1290 |
| 2 | TREPROSTINIL | 557 |
| 3 | LEVONORGESTREL | 382 |
| 4 | SILDENAFIL CITRATE | 350 |
| 5 | MACITENTAN | 333 |
| 6 | ERGOCALCIFEROL | 320 |
| 7 | TADALAFIL | 320 |
| 8 | AMBRISENTAN | 318 |
| 9 | ACETAMINOPHEN | 308 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | URIDINE TRIACETATE | 23 | 0.1544 |
| 1 | ETONOGESTREL | 6622 | 0.1150 |
| 2 | COPPER | 1290 | 0.0299 |
| 3 | GEMCITABINE INTRAVESICAL | 10 | 0.0207 |
| 4 | EPOPROSTENOL | 207 | 0.0158 |
| 5 | SOTATERCEPT-CSRK | 85 | 0.0137 |
| 6 | PSYLLIUM HUSK | 17 | 0.0126 |
| 7 | TEDUGLUTIDE | 169 | 0.0126 |
| 8 | IDURSULFASE | 50 | 0.0125 |
| 9 | ERGOCALCIFEROL | 320 | 0.0108 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 7061 |
| 1 | Copper-containing Intrauterine Device [EPC] | 1293 |
| 2 | Prostacycline Vasodilator [EPC] | 736 |
| 3 | Endothelin Receptor Antagonist [EPC] | 634 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 610 |
| 5 | Corticosteroid [EPC] | 416 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 407 |
| 7 | Benzodiazepine [EPC] | 395 |
| 8 | Progestin-containing Intrauterine System [EPC] | 382 |
| 9 | Loop Diuretic [EPC] | 331 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Copper-containing Intrauterine Device [EPC] | 1293 | 0.0261 |
| 1 | Progestin [EPC] | 7061 | 0.0242 |
| 2 | Interleukin-5 Antagonist [EPC] | 12 | 0.0174 |
| 3 | GLP-2 Analog [EPC] | 169 | 0.0126 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 25 | 0.0120 |
| 5 | Provitamin D2 Compound [EPC] | 320 | 0.0108 |
| 6 | Plasma Kallikrein Inhibitor [EPC] | 21 | 0.0088 |
| 7 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 89 | 0.0066 |
| 8 | Human Antihemophilic Factor [EPC] | 1 | 0.0065 |
| 9 | Adrenocorticotropic Hormone [EPC] | 5 | 0.0056 |